Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.07 USD | +0.63% | +3.30% | +14.40% |
04-03 | KARL STORZ SE & Co. KG entered into an agreement to acquire Asensus Surgical, Inc. for $100 million. | CI |
03-26 | Bluebird bio to Restate Financial Statements; Shares Fall | MT |
Sales 2024 * | 504M 688M | Sales 2025 * | 536M 733M | Capitalization | 3.06B 4.18B |
---|---|---|---|---|---|
Net income 2024 * | 326M 446M | Net income 2025 * | 336M 459M | EV / Sales 2024 * | 6.07 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.7 x |
P/E ratio 2024 * |
9.32
x | P/E ratio 2025 * |
9.55
x | Employees | - |
Yield 2024 * |
8.39% | Yield 2025 * |
8.67% | Free-Float | 98.08% |
Latest transcript on Hercules Capital, Inc.
1 day | +0.63% | ||
1 week | +3.30% | ||
Current month | +3.36% | ||
1 month | +4.67% | ||
3 months | +8.60% | ||
6 months | +24.64% | ||
Current year | +14.40% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Bluestein
CEO | Chief Executive Officer | 45 | 10-11-16 |
Seth H. Meyer
DFI | Director of Finance/CFO | 55 | 19-03-03 |
Kiersten Botelho
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gayle Crowell
BRD | Director/Board Member | 73 | 19-02-03 |
Chairman | 71 | 06-02-28 | |
Director/Board Member | 61 | 23-09-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 19.07 | +0.63% | 830,046 |
24-04-25 | 18.95 | -0.05% | 549,175 |
24-04-24 | 18.96 | +0.58% | 620,726 |
24-04-23 | 18.85 | +0.86% | 897,653 |
24-04-22 | 18.69 | +1.25% | 830,645 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.40% | 3.06B | |
+31.41% | 12.02B | |
+2.96% | 1.42B | |
+1.15% | 616M | |
+35.79% | 577M | |
-10.84% | 579M | |
-4.17% | 492M | |
+33.85% | 488M | |
+3.90% | 304M | |
+65.35% | 301M |
- Stock Market
- Equities
- HTGC Stock